The technology vendor is going outside the company to hire PNC vet Michael Lyons to replace Trump Administration-bound Frank Bisignano, leaving the Pittsburgh-bank without its heir apparent for the ...
Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 14.59% ...
Intra-Cellular Therapies Inc (ITCI) stock saw a modest uptick, ending the day at $126.5 which represents a slight increase of $0.30 or 0.24% from the prior close of $126.2. The stock opened at $126.64 ...